Abstract:Background: New chemotherapeutics are urgently required to treat Candida infections caused by drug-resistant strains. Methods: The effects of 16 1,10-phenanthroline (phen)/1,10-phenanthroline-5,6-dione/dicarboxylate complexed with Mn(II), Cu(II) and Ag(I) were evaluated against ten different Candida species. Results: Proliferation of Candida albicans , Candida dubliniensis , Candida famata , Candida glabrata , Candida guilliermondii , Candida kefyr , Candida krusei , Candida lusitaniae , Candida parapsilosis and Candida tropicalis was inhibited by three of six Cu(II) (MICs 1.52–21.55 μM), three of three Ag(I) (MICs 0.11–12.74 μM) and seven of seven Mn(II) (MICs 0.40–38.06 μM) complexes. Among these [Mn 2 (oda)(phen) 4 (H 2 O) 2 ][Mn 2 (oda)(phen) 4 (oda) 2 ].4H 2 O, where oda = octanedioic acid, exhibited effective growth inhibition (MICs 0.4–3.25 μM), favorable activity indexes, low toxicity against Vero cells and good/excellent selectivity indexes (46.88–375). Conclusion: [Mn 2 (oda)(phen) 4 (H 2 O) 2 ][Mn 2 (oda)(phen) 4 (oda) 2 ].4H 2 O represents a promising chemotherapeutic option for emerging, medically relevant and drug-resistant Candida species. Candida species are widespread fungi that can cause a variety of infections in humans, and some of them exhibit resistance profile to existing antifungal drugs. Consequently, it is imperative to discover novel treatments for these clinically relevant human infections. Complexes are chemical compounds containing metal ion components that are well-known for their antimicrobial properties, including antifungal activity. In the present study, we investigated the effects of 16 novel complexes against ten medically relevant Candida species, including some strains resistant to commonly used clinical antifungals. Our findings revealed that all complexes containing manganese and silver metals effectively inhibited the growth of all Candida species tested, albeit to varying extents. Some of these complexes exhibited superior antifungal activity and lower toxicity to mammalian cells compared to traditional antifungals, such as fluconazole. In conclusion, these new complexes hold promise as a potential novel approach for treating fungal infections, especially those caused by drug-resistant Candida strains.

Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant Candida spp

In Vitro Interactions of Micafungin with Amphotericin B, Itraconazole or Fluconazole Against the Pathogenic Phase of Penicillium Marneffei.

Antifungal activity of tannic acid against Candida spp. and its mechanism of action

Ellagic Acid Potentiates the Inhibitory Effects of Fluconazole Against Candida albicans

Synergistic Antifungal Effect of Fluconazole Combined with Licofelone Against Resistant Candida Albicans

Antibiofilm Activity of Azadirachta indica and Catharanthus roseus and Their Synergistic Effects in Combination with Antimicrobial Agents against Fluconazole-Resistant Candida albicans Strains and MRSA

Antifungal activity of the ethanolic extract and flavonoid avicularin from Myrcia tomentosa (Aubl.) DC. on virulence factors of Candida species

Antifungal activity of propafenone on Candida spp. strains: interaction with antifungals and possible mechanism of action

Analysis of the anti-Candida activity of tricyclic antidepressants in association with amphotericin B and their antifungal mechanisms

Combining Fluconazole with Benzo[a]phenoxazine Derivatives as a Promising Strategy Against Fluconazole-Resistant Candida Species

Does DHN-Melanin Always Protect Fungi against Antifungal Drugs? The Fonsecaea/Micafungin Paradigm

Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole against Candida albicans biofilm

Berberine-fluconazole microparticle-based combination therapy to treat candidiasis infections

Antifungal activity of 2-chloro-N-phenylacetamide: a new molecule with fungicidal and antibiofilm activity against fluconazole-resistant Candida spp.

Batzelladine D, a Marine Natural Product, Reverses the Fluconazole Resistance Phenotype Mediated by Transmembrane Transporters in Candida albicans and Interferes with Its Biofilm: An In Vitro and In Silico Study

Synergistic potential of teriflunomide with fluconazole against resistant Candida albicans in vitro and in vivo

In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis

Paeonol assists fluconazole and amphotericin B to inhibit virulence factors and pathogenicity of Candida albicans

Antifungal activity of Caryocar brasiliense camb. Alone or along with antifungal agents against multidrug-resistant Candida auris

In vitro Evaluation of Fungal Susceptibility and Inhibition of Virulence by Diosgenin

Manganese(II), copper(II) and silver(I) complexes containing 1,10-phenanthroline/1,10-phenanthroline-5,6-dione against Candida species